Display options
Share it on

World J Hepatol. 2019 Feb 27;11(2):173-185. doi: 10.4254/wjh.v11.i2.173.

Hepatic encephalopathy: Lessons from preclinical studies.

World journal of hepatology

Luiza Cioglia Dias Lima, Aline Silva Miranda, Rodrigo Novaes Ferreira, Milene Alvarenga Rachid, Ana Cristina Simões E Silva

Affiliations

  1. Departamento de Patologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais 31270-901, Brasil.
  2. Departamento de Morfologia, Instituto de Ciências Biológicas, UFMG, Belo Horizonte, Minas Gerais 30130-100, Brasil.
  3. Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, UFMG, Belo Horizonte, Minas Gerais 30130-100, Brasil. [email protected].

PMID: 30820267 PMCID: PMC6393717 DOI: 10.4254/wjh.v11.i2.173

Abstract

Hepatic encephalopathy (HE) is a major complication that is closely related to the progression of end-stage liver disease. Metabolic changes in advanced liver failure can promote cognition impairment, attention deficits and motor dysfunction that may result in coma and death. HE can be subdivided according to the type of hepatic injury, namely, type A, which results from acute liver failure, type B, which is associated with a portosystemic shunting without intrinsic liver disease, and type C, which is due to chronic liver disease. Several studies have investigated the pathogenesis of the disease, and most of the mechanisms have been explored using animal models. This article aimed to review the use of preclinical models to investigate HE. The most used animal species are rats and mice. Experimental models of type A HE include surgical procedures and the administration of hepatotoxic medications, whereas models of types B and C HE are generally surgically induced lesions in liver tissue, which evolve to hepatic cirrhosis. Preclinical models have allowed the comprehension of the pathways related to HE.

Keywords: Acute liver failure; Hepatic cirrhosis; Hepatic encephalopathy; Hyperammonemia; Neuroinflammation; Preclinical studies

Conflict of interest statement

Conflict-of-interest statement: The authors declare that they do not have any conflicts of interest.

References

  1. Am J Physiol. 1999 Aug;277(2):G455-62 - PubMed
  2. Int J Exp Pathol. 2000 Apr;81(2):145-57 - PubMed
  3. Br J Exp Pathol. 1975 Oct;56(5):408-11 - PubMed
  4. Am J Med. 2003 Feb 15;114(3):188-93 - PubMed
  5. Gastroenterology. 1976 Jul;71(1):109-13 - PubMed
  6. Surg Gynecol Obstet. 1953 Dec;97(6):748-62 - PubMed
  7. Eur J Clin Invest. 2004 Feb;34(2):122-8 - PubMed
  8. J Hepatol. 2004 Jul;41(1):49-54 - PubMed
  9. J Hepatol. 2005;42 Suppl(1):S115-23 - PubMed
  10. J Hepatol. 2005;42 Suppl(1):S45-53 - PubMed
  11. Metab Brain Dis. 2005 Dec;20(4):399-408 - PubMed
  12. Neurochem Int. 2006 May-Jun;48(6-7):434-40 - PubMed
  13. Hepatology. 2006 Jun;43(6):1257-66 - PubMed
  14. Metab Brain Dis. 2007 Mar;22(1):125-38 - PubMed
  15. Metab Brain Dis. 2007 Dec;22(3-4):375-88 - PubMed
  16. Metab Brain Dis. 2009 Mar;24(1):147-57 - PubMed
  17. J Neurochem. 2009 Apr;109(2):485-93 - PubMed
  18. J Cereb Blood Flow Metab. 2009 May;29(5):944-52 - PubMed
  19. Gastroenterology. 2009 Jun;136(7):2159-68 - PubMed
  20. Liver Int. 2009 Jul;29(6):783-8 - PubMed
  21. Neurochem Int. 2010 Jan;56(2):213-5 - PubMed
  22. Eur J Gastroenterol Hepatol. 2010 May;22(5):526-31 - PubMed
  23. Mol Neurobiol. 2011 Apr;43(2):87-96 - PubMed
  24. Hepatology. 2011 Jul;54(1):204-15 - PubMed
  25. Hepatology. 2011 Apr;53(4):1372-6 - PubMed
  26. J Surg Res. 2011 Oct;170(2):e233-42 - PubMed
  27. J Gastroenterol Hepatol. 2012 Jul;27(7):1167-74 - PubMed
  28. Clin Gastroenterol Hepatol. 2012 Sep;10(9):1034-41.e1 - PubMed
  29. Glia. 2013 Jan;61(1):62-70 - PubMed
  30. Chem Res Toxicol. 2012 Sep 17;25(9):1955-63 - PubMed
  31. Gastroenterology. 1990 Feb;98(2):478-85 - PubMed
  32. Int J Tissue React. 1990;12(1):39-45 - PubMed
  33. Hepatology. 2014 Mar;59(3):1073-83 - PubMed
  34. Nat Rev Neurosci. 2013 Dec;14(12):851-8 - PubMed
  35. Metab Brain Dis. 2014 Dec;29(4):975-82 - PubMed
  36. N Engl J Med. 2013 Dec 26;369(26):2525-34 - PubMed
  37. HPB Surg. 1989 Nov;1(4):297-305; discussion 305-7 - PubMed
  38. J Neuroinflammation. 2014 Jul 10;11:121 - PubMed
  39. Brain Res. 2014 Aug 26;1578:49-59 - PubMed
  40. Hepatology. 2014 Aug;60(2):715-35 - PubMed
  41. Neurochem Res. 2015 Feb;40(2):274-83 - PubMed
  42. Neurochem Res. 2014 Nov;39(11):2127-35 - PubMed
  43. Liver Transpl. 2014 Dec;20(12):1454-61 - PubMed
  44. J Hepatol. 2015 Feb;62(2):437-47 - PubMed
  45. Hepatology. 1989 Apr;9(4):594-601 - PubMed
  46. Acta Physiol (Oxf). 2015 Jun;214(2):261-74 - PubMed
  47. Clin Liver Dis. 2015 Aug;19(3):461-72 - PubMed
  48. Clin Liver Dis. 2015 Aug;19(3):529-37 - PubMed
  49. Hepat Med. 2015 Jul 13;7:37-42 - PubMed
  50. Metab Brain Dis. 2016 Dec;31(6):1283-1287 - PubMed
  51. J Neuroinflammation. 2015 Oct 29;12:195 - PubMed
  52. J Neuroinflammation. 2016 Feb 16;13:41 - PubMed
  53. J Neuroinflammation. 2016 Apr 18;13(1):83 - PubMed
  54. J Neuroinflammation. 2016 Aug 26;13(1):198 - PubMed
  55. CNS Neurosci Ther. 2017 May;23(5):386-394 - PubMed
  56. World J Gastroenterol. 2017 Sep 14;23(34):6321-6329 - PubMed
  57. F1000Res. 2017 Sep 4;6:1637 - PubMed
  58. Gastroenterology. 1989 Feb;96(2 Pt 1):470-8 - PubMed
  59. Am J Manag Care. 2018 Mar;24(4 Suppl):S51-S61 - PubMed
  60. PLoS One. 2018 May 10;13(5):e0197127 - PubMed
  61. Gene Expr. 2018 Aug 22;18(3):171-185 - PubMed
  62. Hepatology. 1987 Jul-Aug;7(4):621-8 - PubMed
  63. J Surg Res. 1988 Aug;45(2):176-80 - PubMed
  64. Exp Mol Pathol. 1974 Oct;21(2):218-36 - PubMed
  65. Exp Mol Pathol. 1968 Oct;9(2):279-90 - PubMed
  66. Can J Physiol Pharmacol. 1968 Mar;46(2):239-45 - PubMed
  67. Br Med J. 1966 Aug 27;2(5512):497-9 - PubMed
  68. Br J Pharmacol Chemother. 1966 Mar;26(3):606-14 - PubMed
  69. Gastroenterology. 1978 Apr;74(4):664-71 - PubMed
  70. J Surg Res. 1984 Oct;37(4):290-4 - PubMed
  71. Toxicology. 1984 May 1;31(1):41-52 - PubMed
  72. Br J Exp Pathol. 1984 Jun;65(3):305-11 - PubMed
  73. Gastroenterology. 1980 Feb;78(2):382-92 - PubMed
  74. Adv Exp Med Biol. 1994;368:1-10 - PubMed
  75. Thorax. 1995 Apr;50(4):399-402 - PubMed
  76. Hepatology. 1995 Mar;21(3):796-804 - PubMed
  77. Transplant Proc. 1994 Jun;26(3):1794-5 - PubMed
  78. Lancet. 1993 Oct 9;342(8876):898-9 - PubMed
  79. Am J Physiol. 1993 Sep;265(3 Pt 1):G572-8 - PubMed
  80. J Clin Invest. 1977 Mar;59(3):386-96 - PubMed
  81. HPB Surg. 1993;6(3):151-62 - PubMed
  82. Toxicology. 1996 Jan 8;106(1-3):197-206 - PubMed
  83. J Hepatol. 1996 Apr;24(4):468-77 - PubMed
  84. Exp Toxicol Pathol. 1995 Nov;47(5):345-51 - PubMed
  85. Mol Med. 1996 Jan;2(1):109-24 - PubMed
  86. Chirurgie. 1996;121(6):470-3 - PubMed
  87. J Gastroenterol Hepatol. 1996 Dec;11(12):1143-54 - PubMed
  88. Surgery. 1997 Feb;121(2):142-9 - PubMed
  89. Pharmacotherapy. 1997 Mar-Apr;17(2):363-70 - PubMed
  90. Hepatology. 1997 Apr;25(4):950-7 - PubMed
  91. Liver Transpl Surg. 1997 Jul;3(4):407-15 - PubMed
  92. Free Radic Biol Med. 1997;23(7):1067-72 - PubMed
  93. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10663-8 - PubMed
  94. Transplantation. 1997 Nov 27;64(10):1398-403 - PubMed
  95. Hepatology. 1998 Apr;27(4):1013-20 - PubMed

Publication Types